Alkermes: Looking to break out

While drug delivery has often been portrayed as an easy route to company-building, in general the promise has exceeded the reality. Alkermes Inc. believes it will be an exception, which will be witnessed by its turn to profitability next year, along with an NDA for its first home-grown program as a promise for more upside to come.

For ALKS, the value premise is that its delivery technologies can do more than make dosing more convenient, but create what are, in effect, new products that actually improve treatment outcomes. ...